AB
CRDF icon

Amalgamated Bank’s Cardiff Oncology CRDF Stock Holding History

Amalgamated Bank’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,948
Closed -$5K – 1902
2025
Q4 		$5K Sell
1,948
-61
-3% -$142 ﹤0.01% 2701
2025
Q3 		$4K Hold
2,009
– – ﹤0.01% 2821
2025
Q2 		$6K Hold
2,009
– – ﹤0.01% 2638
2025
Q1 		$6K Buy
2,009
+654
+48% +$2.59K ﹤0.01% 2571
2024
Q4 		$6K Hold
1,355
– – ﹤0.01% 2651
2024
Q3 		$4K Hold
1,355
– – ﹤0.01% 2805
2024
Q2 		$3K Buy
+1,355
New +$5.11K ﹤0.01% 2909
2022
Q2 		– Sell
-4,585
Closed -$11K – 3063
2022
Q1 		$11K Buy
+4,585
New +$16.2K ﹤0.01% 2937

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return